Delivery Order SPE2DB20D1100-SPE2DB25FE5B1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,728.21 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with a ceiling value of $11,019.75 and a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Chlorothiazide Sodium 500 mg vials, a medication used to treat high blood pressure and fluid retention. The contract is a Firm Fixed Price, Indefinite Delivery type with a ceiling value of $6,557.49 and a period of performance through January 27, 2025. AmerisourceBergen holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 500 mg vials of the pharmaceutical product Chlorothiazide Sodium. The $2,196.85 contract has a completion date of December 22, 2023 and was awarded on December 21, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to supply pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency awarded a $3,238 delivery order contract to Amerisourcebergen Drug Corporation for chlorothiazide sodium 500 mg vials. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued a requirement for this generic diuretic medication. Amerisourcebergen will deliver the vials from its Conshohocken, Pennsylvania facility on a firm fixed price basis, with performance spanning August 25-28, 2023. No subcontractors or...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 500 mg vials of the pharmaceutical drug chlorothiazide sodium, with a ceiling value of $3,399.80 and a completion date of May 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $6,723.42 to supply 500 milligram vials of chlorothiazide. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies to be delivered by October 26, 2023. The delivery order was awarded against an unstated indefinite delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide...
- The Defense Logistics Agency awarded a delivery order valued at $2,745.11 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets in quantities of 1,000 units. This contract, awarded on July 30, 2025, with a completion date of July 31, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.44 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets (100-count units). This competitive award, issued on July 28, 2025, represents a firm fixed price delivery order with an ultimate completion date of July 29, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This federal contract award, SPE2DB20D3103|SPE2DB23FM1E4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorothiazide Sodium 500 mg vials. The $1,030.01 fixed-price delivery order has a completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5B1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,019.94 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Chlorothiazide Sodium is a diuretic medication commonly used in medical treatment, and its inclusion in this procurement reflects the breadth of pharmaceutical commodities available through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/8/25 |